A division of Helius Medical Technologies (Helius), Helius Medical, Inc (HMI) is developing a breakthrough technology as a potential treatment for neurological symptoms caused by disease or trauma.
In 2013, HMI signed a Collaborative Research and Development Agreement (CRADA) with the US Department of Defense to support the clinical, commercial and regulatory development of the Portable Neuromodulation Stimulator (PoNS™ Device.
The PoNS device delivers translingual neurostimulation (TLNS) to potentially alter the capacity, organization and function of brain structures.
